Peter Brenders

Peter Brenders serves as the General Manager for BeiGene in Canada, overseeing the establishment and operation of the affiliate focused on oncology therapies. As the President and Managing Director of TO4 Group Inc., Peter Brenders provides consultancy in the life sciences sector, specializing in commercialization and organizational transformations. Previous roles include CEO at New Brunswick Health Research Foundation, Kontollo Health Inc., and Inagene Diagnostics Inc., where Peter Brenders spearheaded strategic initiatives and market expansion. Peter Brenders has extensive experience at Sanofi Genzyme as General Manager, and served as President and CEO of BIOTECanada, leading initiatives to support the biotechnology industry in Canada. Peter Brenders holds an MBA in Health Services Management from McMaster University, as well as executive education credentials from Stanford and Harvard.